Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-28 Purchase |
2023-10-02 4:37 pm |
Transcode Therapeutics Inc. | RNAZ | Dudley Robert Michael Chief Executive Officer |
98,000 | $0.51 | $49,980 | 180,262 (Direct) |
View |
| 2023-06-20 Purchase |
2023-06-22 6:23 pm |
Transcode Therapeutics Inc. | RNAZ | Dudley Robert Michael Chief Executive Officer |
18,607 | $2.6154 | $48,665 | 82,262 (Direct) |
View |
| 2023-06-09 Purchase(A) |
2023-06-14 4:16 pm |
Transcode Therapeutics Inc. | RNAZ | Dudley Robert Michael Chief Executive Officer |
19,000 | $2.76 | $52,440 | 61,155 (Direct) |
View |
| 2023-06-09 Purchase |
2023-06-13 4:16 pm |
Transcode Therapeutics Inc. | RNAZ | Dudley Robert Michael Chief Executive Officer |
19,000 | $2.76 | $52,440 | 912,114 (Direct) |
View |
| 2022-09-14 Purchase |
2022-09-16 6:44 pm |
Transcode Therapeutics Inc. | RNAZ | Dudley Robert Michael Chief Executive Officer 10% Owner |
20,000 | $1.15 | $23,000 | 893,114 (Direct) |
View |
| 2022-05-27 Purchase |
2022-06-01 4:01 pm |
Transcode Therapeutics Inc. | RNAZ | Dudley Robert Michael Chief Executive Officer 10% Owner |
30,000 | $1.8461 | $55,383 | 873,114 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-19 Option Award |
2023-05-19 8:06 pm |
N/A 2033-05-18 |
Transcode Therapeutics Inc. | RNAZ | Dudley Robert Michael Chief Executive Officer |
735,000 | $0 | 735,000 (Direct) |
View |
| 2022-12-12 Option Award |
2022-12-14 8:11 pm |
N/A 2032-12-11 |
Transcode Therapeutics Inc. | RNAZ | Dudley Robert Michael Chief Executive Officer 10% Owner |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 06:03 am |
N/A 2031-01-31 |
Transcode Therapeutics Inc. | RNAZ | Dudley Robert Michael Chief Executive Officer 10% Owner |
135,000 | $0 | 135,000 (Direct) |
View |
Ownership |
2021-07-08 9:54 pm |
N/A N/A |
Transcode Therapeutics Inc. | RNAZ | Dudley Robert Michael Chief Executive Officer 10% Owner |
0 | $0 | 1,661,965 (Direct) |
View |